Brett Lauring

Linking axonal degeneration to microtubule remodeling by Spastin-mediated microtubule severing

Katia J. Evans, Edgar R. Gomes, Steven M. Reisenweber et al. · The Journal of Cell Biology · 2005 · 222 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV)

Christopher P. Cannon, Darren K. McGuire, Richard E. Pratley et al. · American Heart Journal · 2018 · 205 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Effect of ertugliflozin on glucose control, body weight, blood pressure and bone density in type 2 diabetes mellitus inadequately controlled on metformin monotherapy ( <scp>VERTIS MET</scp> )

Julio Rosenstock, Juan P. Frías, Dénes Páll et al. · Diabetes Obesity and Metabolism · 2017 · 189 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Recognition of C-terminal amino acids in tubulin by pore loops in Spastin is important for microtubule severing

Susan Roehl White, Katia J. Evans, Jeffrey W. Lary et al. · The Journal of Cell Biology · 2007 · 173 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +13

Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The <scp>VERTIS FACTORIAL</scp> randomized trial

Richard E. Pratley, Roy Eldor, Annaswamy Raji et al. · Diabetes Obesity and Metabolism · 2017 · 164 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16